Frankfurt - Delayed Quote EUR

Inovio Pharmaceuticals, Inc. (GBM.F)

1.6200
0.0000
(0.00%)
At close: April 24 at 8:04:42 AM GMT+2
All numbers in thousands
Breakdown
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Assets
113,197.2060
170,951.4230
348,533.3020
495,941.4930
Total Liabilities Net Minority Interest
44,693.4110
53,602.2940
126,170.5460
96,272.0720
Total Equity Gross Minority Interest
68,503.7950
117,349.1290
222,362.7560
399,669.4210
Total Capitalization
68,503.7950
117,349.1290
238,977.5960
414,629.0680
Common Stock Equity
68,503.7950
117,349.1290
222,362.7560
399,669.4210
Capital Lease Obligations
11,865.1870
13,438.5880
15,459.5590
18,063.5150
Net Tangible Assets
68,503.7950
117,349.1290
209,719.5240
386,529.6950
Working Capital
62,504.4660
110,542.8720
218,374.6060
382,703.3120
Invested Capital
68,503.7950
134,119.7830
238,977.5960
414,629.0680
Tangible Book Value
68,503.7950
117,349.1290
209,719.5240
386,529.6950
Total Debt
11,865.1870
30,209.2420
32,074.3990
33,023.1620
Net Debt
--
2,459.7920
--
--
Share Issued
36,099.9910
22,793.0740
21,090.9430
18,115.2400
Ordinary Shares Number
36,099.9910
22,793.0740
21,090.9430
18,115.2400
Preferred Shares Number
0.0090
0.0090
0.0090
0.0260
12/31/2021 - 4/7/2005

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers